{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:27:44Z","timestamp":1769725664054,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jdcr.2023.09.033","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T18:25:02Z","timestamp":1697048702000},"page":"26-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis"],"prefix":"10.1016","volume":"42","author":[{"given":"Nicole","family":"Trepanowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca M.","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Wetstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Servattalab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subin","family":"Jacob-George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2023.09.033_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19022","article-title":"The possible role of Wnt\/\u03b2-catenin signalling in vitiligo treatment","author":"Lin","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jdcr.2023.09.033_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.gendis.2020.06.003","article-title":"SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt\/\u03b2-catenin signaling","volume":"8","author":"Zou","year":"2021","journal-title":"Genes Dis"},{"issue":"12","key":"10.1016\/j.jdcr.2023.09.033_bib3","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: A promising target for repigmenting vitiligo patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdcr.2023.09.033_bib4","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.102038","article-title":"Bone morphogenetic proteins differentially regulate pigmentation in human skin cells","author":"Singh","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jdcr.2023.09.033_bib5","series-title":"StatPearls. StatPearls Publishing","article-title":"Romosozumab","author":"Krupa","year":"2023"},{"issue":"9","key":"10.1016\/j.jdcr.2023.09.033_bib6","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/jdv.15604","article-title":"Clinical visible signs of disease activity in vitiligo: a systematic review and meta-analysis","volume":"33","author":"van Geel","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdcr.2023.09.033_bib7","article-title":"Sclerostin suppression facilitates uveal melanoma progression through activating Wnt\/\u03b2-catenin signaling via binding to membrane receptors LRP5\/LRP6","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jdcr.2023.09.033_bib8","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2147\/DDDT.S127568","article-title":"Profile of Romosozumab and its potential in the management of osteoporosis","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des Dev Ther"},{"issue":"3","key":"10.1016\/j.jdcr.2023.09.033_bib9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1755-148X.2011.00838.x","article-title":"Koebner\u2019s phenomenon in vitiligo: European position paper","volume":"24","author":"van Geel","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jdcr.2023.09.033_bib10","doi-asserted-by":"crossref","DOI":"10.3238\/arztebl.m2022.0067","article-title":"Paradoxical reactions to BioLogicals in chronic inflammatory systemic diseases","author":"Kremenevski","year":"2022","journal-title":"Dtsch \u00c4rztebl Int"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623003806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623003806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:27Z","timestamp":1762475127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623003806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":10,"alternative-id":["S2352512623003806"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.09.033","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}